Nutex Health
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Nutex Health generated cash of $1,256,452, which is less than the previous year. Cash used in financing activities reached the amount of -$2,269,778 last year. Net change in cash is therefore -$12,253,208.
Cash Flow
| 2015 | 44.90K | 1.82K | -51.27K |
|---|---|---|---|
| 2016 | -274.22K | -9.99K | 172.44K |
| 2017 | -714.62K | 2.05K | 711.5K |
| 2018 | -480.04K | -116.96K | 704.57K |
| 2019 | 12.12M | -31.23M | 21.71M |
| 2020 | 81.26M | -61.19M | -2.56M |
| 2021 | 173.43M | -36.97M | -125.85M |
| 2022 | 50.60M | -4.33M | -48.13M |
| 2023 | 1.25M | -11.23M | -2.26M |
NUTX Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 34.25M | 36.11M | 25.51M | 8.00M | 5.40M | 9.44K | 10.52K | 122.29K | 126.83K |
Operating activities | |||||||||
Net income | -45.78M | -432.73M | 168.52M | 145.55M | 32.08M | -950.12K | -6.00M | -451.06K | -536.13K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 17.59M | 13.13M | 7.66M | 5.96M | 2.47M | 522 | 535.02K | 473 | 662 |
Stock-based compensation expense | 2.83M | 189.58K | 0 | 0 | 450.05K | 0 | 924.32K | 0 | 0 |
| Deferred income tax benefit | 2.83M | 189.58K | 0 | 0 | 450.05K | 0 | 924.32K | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -4.58M | 58.07M | -6.62M | -71.23M | -24.74M | -82.08K | -4.00K | 0 | 56.69K |
Inventories | 142.70K | -719.10K | -1.08M | -825.77K | -486.27K | 127 | 0 | 0 | 0 |
Accounts payable | -2.24M | 9.68M | 6.26M | 2.58M | 1.63M | 402.24K | 119.21K | 187.03K | 77.79K |
Cash generated by operating activities | 1.25M | 50.60M | 173.43M | 81.26M | 12.12M | -480.04K | -714.62K | -274.22K | 44.90K |
Investing activities | |||||||||
Purchases Of Investments | 0 | 0 | 0 | 60.9K | -100K | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -9.49M | -14.63M | -36.92M | -61.19M | -32.27M | 0 | 0 | 0 | 0 |
Acquisitions Net | -1.74M | 10.29M | -48.85K | 500 | 1.04M | -116.96K | -30.79K | 0 | 0 |
Cash generated by investing activities | -11.23M | -4.33M | -36.97M | -61.19M | -31.23M | -116.96K | 2.05K | -9.99K | 1.82K |
Financing activities | |||||||||
Common Stock Issued | 0 | 4.11M | 0 | 120K | 4.11M | 30K | 275K | 0 | 0 |
Payments for dividends | 0 | -51.23M | -144.33M | -59.05M | -18.90M | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -120K | -4.11M | 0 | 0 | 0 | 0 |
Repayments of term debt | 2.64M | -5.59M | -22.83M | -15.36M | 35.56M | -337.27K | 461K | -48.46K | 0 |
Cash used in financing activities | -2.26M | -48.13M | -125.85M | -2.56M | 21.71M | 704.57K | 711.5K | 172.44K | -51.27K |
Net Change In Cash | -12.25M | -1.86M | 10.60M | 17.51M | 2.60M | 109.81K | -1.07K | -111.76K | -4.54K |
Cash at end of period | 22.00M | 34.25M | 36.11M | 25.51M | 8.00M | 119.26K | 9.44K | 10.52K | 122.29K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |